Oral Hypoglycemic Agents - ECAB book cover

Oral Hypoglycemic Agents - ECAB

Even though we have many advances in the development of oral hypoglycemic agents, an ideal drug for treating type 2 diabetes is still a distant reality. Today, physicians can choose from a variety of medications targeting numerous facets of disease, but each drug class poses some limitations. The age-old molecules, such as sulfonylureas and biguanides, are still valued because of their well-studied mode of action, safety, tolerability, and predictable pharmacodynamic effects. This book attempts to describe the historical aspects and advances in the arena of oral hypoglycemic agents, extended- and sustained-release formulations of glipizide and metformin (both of which have great promise in the treatment of type 2 diabetes mellitus) as well as evaluates the role of the group in diabetic foot infections.

,

Published: July 2013

Imprint: Elsevier

ISBN: 978-81-312-3216-3

Contents

  • Introduction

    Oral Hypoglycemic Agents: Historical Perspectives and Current Trends

    Emerging and Future Concepts of Oral Hypoglycemic Agents

    Metformin: An Old Drug Rediscovered

    Oral Hypoglycemic Agents and Diabetic Foot

    Other Books in This Series

Advertisement

advert image